News & Updates

Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
31 Jul 2023

In patients with neovascular age-related macular degeneration (nAMD) who switched to brolucizumab treatment, those with shorter treatment interval before switching are more likely to have successful injection interval extension, as shown in a study.

Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
31 Jul 2023
Amblyopia protective against age-related macular degeneration
Amblyopia protective against age-related macular degeneration
14 Jul 2023

Less amblyopic individuals are more likely to have age-related macular degeneration (AMD) diagnosed on the amblyopic eye than on the nonamblyopic eye, as reported in a study. Meanwhile, individuals with lateral asymmetry tend to have the more advanced form of AMD on the nonamblyopic eye.

Amblyopia protective against age-related macular degeneration
14 Jul 2023